Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

James Rickard appointed Chief Scientific Officer of Richmond Research Institute

13
June 2023

James Rickard is a Research Pharmacist and has been involved in translational research to deliver new therapeutic options to patients throughout his career. Driven by his desire for better outcomes for patients, he spent his early career working across several London Teaching Hospitals in Clinical Pharmacy, Drug Manufacture and Clinical Trials, culminating in taking up the role of Deputy Chief Pharmacist for Barts Health NHS Trust.

View Articles

Richmond Pharmacology at the BCS 2023 conference

9
June 2023

Read more about how Richmond Pharmacology have supported the British Cardiovascular Society this month

View Articles

Celebrating Clinical Trials Day 2023

19
May 2023

This year, we will be celebrating Clinical Trials Day alongside our workforce, sponsors and industry colleagues.

View Articles

Bridging the gap in Phase 1 clinical studies

17
April 2023

Here at Richmond Pharmacology, we focus mainly on Japanese cohorts in order to fast track global marketing authorisations in these important markets, ultimately reaching patients sooner.

View Articles

Futureproofing early phase clinical research for the next generation of investigators.

20
March 2023

Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.

View Articles

How Does Social Time Contribute to a Positive Workplace Culture?

13
March 2023

Read the blog by Richmond Pharmacology’s Chair of the Social Committee and Head of Marketing, Elizabeth Romano about how being social improves organisational culture and embeds the core values.

View Articles

Latest news

Richmond Pharmacology Announces Promotion of Dr Priscilla Ochuba to Associate Medical Director

August 1, 2025
Richmond Pharmacology is pleased to announce the promotion of Dr Priscilla Ochuba to Associate Medical Director, effective 1st August 2025.
Read more

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Events

JSCPT 2025

5th –6th December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event